Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Case ReportCase Studies

A Case Study to Address a Gap in the Device-to-Vial Interface Stopper Push-in by Chemo Spikes

Xia (Cathy) Zhao, Le Ho, Daniel Bantz, Doug Hostetler and Liang Fang
PDA Journal of Pharmaceutical Science and Technology January 2019, 73 (1) 92-109; DOI: https://doi.org/10.5731/pdajpst.2018.008664
Xia (Cathy) Zhao
West Pharmaceutical Services, Inc., 530 Herman O. West Drive, Exton, PA 19341
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Cathy.Zhao@westpharma.com
Le Ho
West Pharmaceutical Services, Inc., 530 Herman O. West Drive, Exton, PA 19341
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Bantz
West Pharmaceutical Services, Inc., 530 Herman O. West Drive, Exton, PA 19341
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Doug Hostetler
West Pharmaceutical Services, Inc., 530 Herman O. West Drive, Exton, PA 19341
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liang Fang
West Pharmaceutical Services, Inc., 530 Herman O. West Drive, Exton, PA 19341
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

This case study is the first to address the risk, at the device-to-vial interface, of a spike pushing a stopper into a vial. It was performed after healhcare workers at cancer care hospitals complained about the risk of possible exposure to hazardous injectable drugs during the transfer if the spike pushed the stopper into the vial. This case study took a three-step approach to understand the device-to-vial interface and the factors that determine stopper push-in force threshold and spike puncture force, respectively. The results show that the stopper push-in force threshold varies with the spike size, stopper properties, and stopper design, while the spike puncture force is determined by spike design, spike surface lubricity, stopper properties, and stopper design. This case study suggests that to mitigate the risk of stopper push-in, the spike puncture force needs to be significantly lower than the stopper push-in force threshold, measured with a flat-tip test probe having the same outside diameter as typically used spikes. In addition, although some factors that impact stopper push-in force threshold also impact spike puncture force in the same trend, such as stopper material, other factors that impact stopper push-in force threshold do not impact spike puncture force and vice versa. For example, the spike length and cross-section area contribute to stopper push-in force threshold but do not have significant impact on puncture force. It would be misleading to just compare the absolute values of spike puncture forces but neglect the dimensional factors. From the stopper and spike compatibility perspective, this case study provides a methodology to quantify the risk of the stopper being pushed into the vial by the spike and suggests a process to prevent the stopper push-in from occurring. The study also shows that the human factor is another important element in the stopper push-in issue. It emphasizes the need for a joint effort for risk mitigation across the board among stopper manufacturers, spike manufacturers, pharmaceutical manufacturers, device manufacturers, and hospitals (pharmacies and healthcare workers). Device and drug developers need to properly select and test stoppers and containers with intended spikes. Healthcare workers need to use compatible stoppers and spikes and need to use them correctly.

LAY ABSTRACT: It is critical to protect healthcare workers from exposure to hazardous drugs such as cancer drugs. Since the 1970s, much work has focused on the development of closed-system drug-transfer devices (CSTD) to ensure the containment of spills, sprays, and vapors. However, other gaps in the cancer drug transfer process have been overlooked. For example, one gap at the device-to-stopper interface is the compatibility of vial stopper and spike. This case study is the first to address the risk at the device-to-vial interface of stopper push-in by the spikes during the transfer of hazardous injectable drugs. It serves to understand the issue of spikes pushing stoppers into the vial. It shows that the push-in force threshold varies with the spike diameters, stopper materials, and design. The spike puncture force is impacted by spike design, surface lubricity, stopper materials, and design. To prevent the stopper from being pushed into the vial, causing splashes and exposure to the drug, it is important to coordinate the stopper push-in force threshold and spike puncture force and optimize the spike dimensions. The human factor also affects the drug transfer. This case study provides a methodology to quantify the stopper push-in risk from a force and dimensional perspective.

  • Stopper push-in
  • Spikes
  • Vial-to-device
  • Drug transfer system
  • Needleless
  • Hazardous drug transfer
  • © PDA, Inc. 2019
View Full Text

PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.  

If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing. 

Full issue PDFs are for PDA members only.

Note to pda.org users

The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.

Log in using your username and password

Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles

Full issue PDFs are for PDA members only. You can join PDA at www.pda.org. 

PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 73 (1)
PDA Journal of Pharmaceutical Science and Technology
Vol. 73, Issue 1
January/February 2019
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Case Study to Address a Gap in the Device-to-Vial Interface Stopper Push-in by Chemo Spikes
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
A Case Study to Address a Gap in the Device-to-Vial Interface Stopper Push-in by Chemo Spikes
Xia (Cathy) Zhao, Le Ho, Daniel Bantz, Doug Hostetler, Liang Fang
PDA Journal of Pharmaceutical Science and Technology Jan 2019, 73 (1) 92-109; DOI: 10.5731/pdajpst.2018.008664

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A Case Study to Address a Gap in the Device-to-Vial Interface Stopper Push-in by Chemo Spikes
Xia (Cathy) Zhao, Le Ho, Daniel Bantz, Doug Hostetler, Liang Fang
PDA Journal of Pharmaceutical Science and Technology Jan 2019, 73 (1) 92-109; DOI: 10.5731/pdajpst.2018.008664
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results and Discussions
    • Conclusion
    • Declaration
    • Conflict of Interest Declaration
    • Acknowledgment
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Survey Report on Complaints Related to the Interconnectivity between Vial Containers and Transfer Devices
  • Google Scholar

More in this TOC Section

  • Phase-Incremental Decision Trees for Multi-Phase Feature Selection and Interaction in Biologics Manufacturing
  • Practical Application of Setting up an Annual Contamination Control Strategy (CCS) Assessment
  • A Risk Assessment and Risk Based Approach Review of Pre-use/Post Sterilization Integrity Testing (PUPSIT)
Show more Case Studies

Similar Articles

Keywords

  • Stopper push-in
  • Spikes
  • Vial-to-device
  • Drug transfer system
  • Needleless
  • hazardous drug transfer

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire